Skip to main content
. 2010 Apr 6;5(4):e10038. doi: 10.1371/journal.pone.0010038

Table 1. Clinical data of anemic and non-anemic patients on admission.

Total study population (n = 91) Group MM (n = 52) Group SMA (n = 39) p-value
Hb (g/dl) 8.0 (4.9–10.0) 10 (8.7–10.5) 4.9 (4.4–5.3) -a
Hct (%) 23.9 (14.9–29.0) 28.1 (25.9–30.6) 14.3 (12.3–16.0) -a
RBCs (106 cells/µl) 3.27 (2.19–3.90) 3.87 (3.50–4.30) 1.93 (1.60–2.30) -a
Parasitemia (per µl) 20,200 (6,960–76,000) 23,800 (8,880–69,000) 12,000 (5,880–101,600) 0.81b
Reticulocytes (%) 2.4 (1.4–5.2) 1.8 (1.3–2.5) 5.3 (2.3–10.6) <0.0001b
MCV (fl) 72.6 (68.6–76.8) 71.8 (67.9–76.0) 74.0 (69.3–78.1) 0.15b
Age (months) 32 (22–50) 36 (23–53) 27 (20–43) 0.13b
Weight (kg) 13.0 (10.8–15.0) 13.5 (11.0–15.0) 11.4 (9.8–14.0) 0.04b
Height (cm) 89 (81–100) 90 (83–104) 87 (76–96) 0.12b
# Sex (male/female) 45/46 26/26 19/20 1c
# Sickle cell trait 8 6 2 0.46c
# Blood transfusion 17 0 17 <0.0001c

MM: mild malaria, SMA: severe malarial anemia, Hb: hemoglobin, Hct: hematocrit, RBCs: red blood cells, MCV: mean corpuscular volume, results are in median (interquartile ranges) and count data (#).

a

parameter used for group definition - no p-value calculated, bKruskal-Wallis rank sum test, cχ2-test.